Concerns about global warming kicked into high gear for Aryan Gurusamy as plumes of smoke from Canadian wildfires cloaked the Northeast. Now he and a fellow first-year student are competing for a $10,000 prize for a startup to address carbon emissions.
IntelliGenes, a first-of-its-kind software created at Rutgers Health, combines artificial intelligence (AI) and machine-learning approaches to measure the significance of specific genomic biomarkers to help predict diseases in individuals, according to its developers.
Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer.
A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person’s white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels.
A Rutgers research project focused on offshore wind energy is poised to make New Jersey a global leader in the field in a little more than a decade.
Using advanced research techniques, Rutgers Health–led scientists have shed light on how chronic fatigue syndrome and fibromyalgia are related, paving the way to even bigger breakthroughs.
SARS-CoV-2 will eventually become resistant to the only effective oral treatment, Paxlovid, scientists say. The world needs another.
Students who reported higher levels of school connectedness showed lower levels of aggressive behaviors and depression six years later, Rutgers researchers find.
Lily Young, a Distinguished Professor of Environmental Microbiology at Rutgers University–New Brunswick, received the Daniel Gorenstein Memorial Award for outstanding scholarly achievement and exceptional service.
Researchers from Rutgers and other institutions have uncovered significant variations in how inflammatory bowel disease (IBD) affects people of different races, sexes and places of birth.
Rutgers professor and other researchers perform a systematic review and meta-analysis to evaluate studies comparing perinatal outcomes among individuals with gestational diabetes mellitus.
